|
|
|
瑞銀(盧森堡)生化股票基金
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
649.80 |
9.69 |
1.51% |
2019/12/03 |
|
|
| 2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
| 17.40% |
14.32% |
1.85% |
32.71% |
54.62% |
41.28% |
1.57% |
-17.08% |
25.45% |
-13.98% |
| 瑞銀(盧森堡)生化股票基金(美元)
| |
本基金主要投資於全球生化科技產業中從事研究、產品開發、產品製造及配銷的公司股票;選股著重於個別公司之市場地位及該公司之管理與獲利能力，以獲得來自該產業的利益。本基金的投資目標在於透過積極的基金管理方式，達到最佳之投資績效，同時將投資風險降至最低。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2019/12/03 |
649.80 |
1.51% |
2019/11/18 |
610.22 |
0.14% |
| 2019/12/02 |
640.11 |
-0.67% |
2019/11/15 |
609.34 |
1.25% |
| 2019/11/29 |
644.44 |
-0.18% |
2019/11/14 |
601.80 |
-0.84% |
| 2019/11/27 |
645.59 |
0.81% |
2019/11/13 |
606.89 |
0.38% |
| 2019/11/26 |
640.43 |
0.00% |
2019/11/12 |
604.60 |
0.72% |
| 2019/11/25 |
640.40 |
2.66% |
2019/11/11 |
600.26 |
-0.36% |
| 2019/11/22 |
623.79 |
0.37% |
2019/11/08 |
602.41 |
2.45% |
| 2019/11/21 |
621.47 |
0.28% |
2019/11/07 |
587.99 |
0.09% |
| 2019/11/20 |
619.71 |
0.19% |
2019/11/06 |
587.49 |
-0.79% |
| 2019/11/19 |
618.52 |
1.36% |
2019/11/05 |
592.14 |
0.08% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
1.51% |
1.46% |
12.06% |
18.62% |
18.64% |
10.60% |
27.93% |
| NBI生技指數 |
-1.40% |
-0.50% |
8.45% |
15.82% |
14.93% |
11.24% |
22.49% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-0.12% |
0.81% |
12.20% |
17.39% |
12.02% |
9.48% |
19.73% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
-0.33% |
5.11% |
8.91% |
12.19% |
9.28% |
16.95% |
| MSCI 製藥指數 (price) |
0.00% |
-0.13% |
3.56% |
7.10% |
9.28% |
5.55% |
12.39% |
| MSCI 生物科技指數 (price) |
0.00% |
-0.59% |
6.23% |
16.70% |
19.03% |
10.31% |
15.06% |
|
0.58% |
-0.50% |
3.94% |
10.25% |
12.37% |
10.89% |
17.98% |
|
0.57% |
-0.52% |
3.85% |
9.98% |
11.81% |
9.79% |
16.90% |
|
0.51% |
-0.26% |
9.48% |
15.69% |
18.67% |
10.71% |
29.29% |
|
0.58% |
0.17% |
8.03% |
11.04% |
10.90% |
1.85% |
18.00% |
|
0.74% |
-1.25% |
4.12% |
6.66% |
16.91% |
12.86% |
23.99% |
|
0.97% |
-0.26% |
3.76% |
7.60% |
15.45% |
10.08% |
20.48% |
|
0.78% |
-0.26% |
6.26% |
10.58% |
13.66% |
11.13% |
20.37% |
|
0.68% |
-0.30% |
4.07% |
2.57% |
6.71% |
6.23% |
15.19% |
|
0.70% |
-0.28% |
3.74% |
5.49% |
10.09% |
6.96% |
16.04% |
|
-0.37% |
-2.42% |
-3.10% |
11.95% |
35.10% |
0.00% |
38.95% |
|
0.74% |
-1.11% |
4.49% |
6.00% |
14.34% |
14.14% |
24.02% |
|
0.72% |
1.85% |
10.39% |
19.54% |
15.49% |
16.03% |
31.23% |
|
0.71% |
1.81% |
10.29% |
19.14% |
14.73% |
14.54% |
29.65% |
|
0.21% |
0.06% |
5.66% |
10.94% |
15.33% |
11.55% |
24.18% |
|
1.18% |
0.75% |
7.39% |
11.83% |
13.42% |
13.66% |
23.26% |
|
1.18% |
0.72% |
7.29% |
11.53% |
12.84% |
12.51% |
22.11% |
|
1.18% |
0.77% |
7.24% |
11.06% |
11.72% |
9.96% |
19.64% |
|
1.18% |
0.75% |
7.30% |
11.27% |
12.13% |
10.75% |
20.47% |
|
1.18% |
0.77% |
7.47% |
12.02% |
13.83% |
14.51% |
24.13% |
|
0.17% |
-0.44% |
4.54% |
7.74% |
10.06% |
4.97% |
17.47% |
|
0.65% |
0.15% |
9.91% |
16.17% |
14.77% |
8.32% |
25.09% |
|
0.42% |
-0.86% |
10.46% |
15.96% |
17.91% |
14.81% |
32.68% |
|
0.67% |
0.15% |
10.08% |
16.99% |
16.44% |
11.99% |
28.92% |
|
1.03% |
-0.08% |
4.30% |
5.50% |
10.14% |
3.04% |
16.05% |
|
0.81% |
-1.09% |
4.83% |
5.30% |
13.19% |
9.13% |
23.02% |
|
1.06% |
-0.08% |
4.47% |
6.23% |
11.77% |
6.45% |
19.53% |
|
-0.09% |
-0.47% |
5.87% |
9.99% |
15.41% |
10.95% |
24.93% |
|
0.56% |
0.37% |
7.54% |
12.68% |
15.81% |
14.59% |
24.60% |
|
0.76% |
0.51% |
7.28% |
14.70% |
16.37% |
14.70% |
24.76% |
| 基金平均績效 |
0.72% |
0.00% |
6.43% |
11.17% |
14.53% |
10.26% |
23.36% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
